Patents by Inventor Stephane Naudin

Stephane Naudin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9486317
    Abstract: Methods of arthroscopic resurfacing of a joint utilizing a biological component strengthened with fibrin glue. The biological component is selected from the group consisting of PRP, bone marrow aspirate (BMA) and autologous conditioned plasma (ACP). The biological component/fibrin glue composition may be inserted (by injection or by employing a biologic resurfacing mold, for example) into a transosseous tunnel in the vicinity of the defect to be repaired. Upon insertion at the defect site, the biological component/fibrin glue composition is designed to coagulate and solidify within few minutes, to advance the healing of the damaged tissue and tissue growth. The biological component/fibrin glue composition may optionally comprise components such as growth factors, antiseptic chemicals and/or antibiotics and/or electrolytes, or hormones or site-specific hybrid proteins, among others.
    Type: Grant
    Filed: August 26, 2008
    Date of Patent: November 8, 2016
    Assignee: Arthrex Inc.
    Inventors: Giuseppe Milano, Gerlinde Michel, Stephane Naudin, Hans Linden, Reinhold Schmieding
  • Patent number: 8535703
    Abstract: Methods of arthroscopic resurfacing of anatomical tissue utilizing a biological component strengthened with glue or similar material. The biological component is selected from the group consisting of blood, blood components, PRP, bone marrow aspirate (BMA) and autologous conditioned plasma (ACP). The biological component/glue composition may be inserted (by injection and/or by employing a biologic resurfacing mold, for example) into, or in the vicinity of, the anatomical tissue. Upon insertion within, or contact with, the anatomical tissue, the biological component/glue composition is designed to coagulate and solidify (or partially solidify) within minutes, to advance healing or tissue growth of the anatomical tissue. The biological component/glue composition may optionally comprise components such as growth factors, antiseptic chemicals and/or antibiotics and/or electrolytes, or hormones or site-specific hybrid proteins, among others.
    Type: Grant
    Filed: August 26, 2008
    Date of Patent: September 17, 2013
    Assignee: Arthrex, Inc.
    Inventors: Reinhold Schmieding, Gerlinde Michel, Stephane Naudin, Hans Linden
  • Patent number: 8348960
    Abstract: A technique for joint repair employing a suture/button construct and an applicator designed to securely engage a button of the suture/button construct. The button of the suture/button construct securely engages the shaft of the applicator. The suture from the button may be wrapped around a securing device (for example, a rod or bolt) located on or within the handle. The applicator with the secured button is introduced into the tissue (for example, soft tissue or a bone tunnel) and the button is passed through the tissue.
    Type: Grant
    Filed: July 3, 2008
    Date of Patent: January 8, 2013
    Assignee: Arthrex, Inc.
    Inventors: Gerlinde Michel, Benedikt Bodinger, Karen L. Gallen, Stephane Naudin
  • Publication number: 20090060974
    Abstract: Methods of arthroscopic resurfacing of anatomical tissue utilizing a biological component strengthened with glue or similar material. The biological component is selected from the group consisting of blood, blood components, PRP, bone marrow aspirate (BMA) and autologous conditioned plasma (ACP). The biological component/glue composition may be inserted (by injection and/or by employing a biologic resurfacing mold, for example) into, or in the vicinity of, the anatomical tissue. Upon insertion within, or contact with, the anatomical tissue, the biological component/glue composition is designed to coagulate and solidify (or partially solidify) within minutes, to advance healing or tissue growth of the anatomical tissue. The biological component/glue composition may optionally comprise components such as growth factors, antiseptic chemicals and/or antibiotics and/or electrolytes, or hormones or site-specific hybrid proteins, among others.
    Type: Application
    Filed: August 26, 2008
    Publication date: March 5, 2009
    Inventors: Reinhold Schmieding, Gerlinde Michel, Stephane Naudin, Hans Linden
  • Publication number: 20090062870
    Abstract: Methods of arthroscopic resurfacing of a joint utilizing a biological component strengthened with fibrin glue. The biological component is selected from the group consisting of PRP, bone marrow aspirate (BMA) and autologous conditioned plasma (ACP). The biological component/fibrin glue composition may be inserted (by injection or by employing a biologic resurfacing mold, for example) into a transosseous tunnel in the vicinity of the defect to be repaired. Upon insertion at the defect site, the biological component/fibrin glue composition is designed to coagulate and solidify within few minutes, to advance the healing of the damaged tissue and tissue growth. The biological component/fibrin glue composition may optionally comprise components such as growth factors, antiseptic chemicals and/or antibiotics and/or electrolytes, or hormones or site-specific hybrid proteins, among others.
    Type: Application
    Filed: August 26, 2008
    Publication date: March 5, 2009
    Inventors: Giuseppe Milano, Gerlinde Michel, Stephane Naudin, Hans Linden, Reinhold Schmieding
  • Publication number: 20090043318
    Abstract: A technique for joint repair employing a suture/button construct and an applicator designed to securely engage a button of the suture/button construct. The button of the suture/button construct securely engages the shaft of the applicator. The suture from the button may be wrapped around a securing device (for example, a rod or bolt) located on or within the handle. The applicator with the secured button is introduced into the tissue (for example, soft tissue or a bone tunnel) and the button is passed through the tissue.
    Type: Application
    Filed: July 3, 2008
    Publication date: February 12, 2009
    Inventors: Gerlinde Michel, Benedikt Bodinger, Karen L. Gallen, Stephane Naudin
  • Publication number: 20080166421
    Abstract: A method of providing autologous conditioned plasma (ACP) for treatment of connective tissue injuries. The method comprises the steps of: (i) providing an apparatus comprising a centrifuge and a double syringe, the double syringe including an inner syringe body and an outer syringe body; (ii) drawing autologous blood into the outer syringe body; (iii) subjecting the autologous blood to at least one centrifugation step to obtain an autologous conditioned plasma (ACP); (iv) removing, with the inner syringe body, at least a portion of autologous conditioned plasma (ACP) from the outer syringe body; and (v) inject ACP for treatment of various cartilage or tendon damage or diseases.
    Type: Application
    Filed: December 21, 2007
    Publication date: July 10, 2008
    Inventors: Michael Buhr, Werner Siekmann, Stephane Naudin